Articles On Invion (ASX:IVX)

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Summary Biopharmaceutical company Bionomics Limited will expand its product pipeline for the treatment of Social Anxiety Disorder (SAD). The Company disclosed that the rapid oral absorption of the novel tablet formulation of BNC210 is...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

A quick wrap of the ASX’s key winners and losers on Friday, September 4. Data is taken after the market closes at 4pm AEST. Today 298 stocks rose, 1,104 declined and 685 were unchanged. WINNERS Code Company Price % Change V...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

From the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a condition characterised by debilitating chronic daily headaches and in some cases severe vision impairment. It’s a poorly treated condi...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

03 Feb 2020 - A subsidiary of Invion (ASX:IVX), EpiTech Dermal Science, has signed an R&D services agreement with a leading China-based pharmaceutical group in the skin repair and …

When US Supreme Court judge Louis Brandeis in 1914 opined that sunlight was the best disinfectant, he was referring to the desirability of transparent legal and government processes. But he could well have been talking about the role of lig...

The health sector was the most successful sector on the ASX in 2019. Various small caps made several breakthroughs including with nerve damage and macular degeneration. While cancer remains one fish that has yet to be fried there are small...

Invion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. The company told shareholders this morning it signed an MoU with Pavay Biotech, an established provider of dermatology treatment products in...

Telecommunications company Uniti Group (ASX:UWL) has topped the list of companies making their debut in 2019 with a whopping 500 per cent gain since listing. The internet service provider’s share price hit $1.50 last Friday to give it a $48...

Here’s our monthly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 92 saw their share prices fall, 32 improved and 13 were flat. >> Scroll down for a table showing the performance of small...

Spies defecting, a foreign power secretly taking control of Australia via 5G, the stealthy infiltration of universities and CSIRO, a new arms race waged through cyber-warfare. This is not a John Le Carre novel, these are the headlines shapi...

Aerial imaging firm Aerometrex (ASX:AMX) has had a strong start to listed life on the ASX, notching a 107 per cent gain in its first two minutes on the bourse. The company doubled its IPO price of $1 on open before edging higher still to a...

While investing in the stock market, an investor comes across various classes of assets, such as equity and bonds. When it comes to investing in equity, there are choices like large-cap, mid-cap and small cap. Investment in small-cap comes...

By the closure of the market session on 29th November 2019, the benchmark index, i.e. S&P/ASX200 was at 6846 with a fall of 18 points from its last close. Besides the decline, some of the companies managed to trade in green and provided...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

For most stocks a double-digit gain in a single day is worthy of celebration. Invion Ltd [ASX:IVX] isn’t like most stocks though… This biotech minnow has made a huge splash today. The Invion share price posting as much as a 200% gain in ear...

One of the best performers on the Australian share market on Wednesday has been the Invion Ltd (ASX: IVX) share price. The clinical-stage drug development company’s shares rocketed an incredible 225% higher at one stage today. They have si...

For a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Over the last two years Invion (ASX:IVX) has been valiantly working against this association, and today says its lasers (not attached to the he...

Life-sciences company Invion (ASX: IVX) has published results from a pre-clinical study that could eventuate into an important development for women’s health. Research conducted by the Hudson Institute of Medical Research in Australia indic...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Melbourne-based Invion (ASX: IVX) will collaborate with world renowned research organisation Peter MacCallum Cancer Centre (Peter Mac) regarding pre-clinical research into the impact of Invion’s photodynamic therapy on penile and anal cance...

Prescient Therapeutics Limited (ASX: PTX) is an Australian clinical stage oncology company that is into the development of personalised medicines for the treatment of multiple cancers. The company aims to develop novel drugs that work on th...

It has been a slow start to the new fiscal year, with the list of planned IPOs thinning out. There’s just seven companies on the ASX’s list of IPOs hoping to hit the boards this month and next. According to the bourse’s market stats, initia...

Biotech company Invex Therapeutics (ASX:IVX) got off to a flyer when it joined the ASX boards on Friday. The company raised $12m at IPO via the issuance of 30m shares at 40c each. The stock commenced trading at 60c and closed on Friday at $...